Onishi Akira, Yamamoto Hisashi, Akimoto Tetsu, Saito Osamu, Inoue Makoto, Ando Yasuhiro, Muto Shigeaki, Kusano Eiji
Division of Nephrology, Department of Medicine, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke-shi, Tochigi, 329-0498, Japan.
Clin Exp Nephrol. 2007 Sep;11(3):241-243. doi: 10.1007/s10157-007-0485-4. Epub 2007 Sep 28.
We describe a 41-year old man with obsessive-compulsive neurosis who developed acute renal failure (ARF) due to acute interstitial nephritis (AIN) during 6 weeks of treatment with clomipramine hydrochloride (CPH). He had a slight fever, mild arthralgia, appetite loss, and diarrhea after taking CPH. On admission, he showed serum creatinine (sCr) of 7.31 mg/dl, and creatinine clearance (Ccr) of 2.5 ml/min. He subsequently became anuric and required hemodialysis. Renal biopsy revealed AIN with diffuse mononuclear cell infiltration. After the withdrawal of CPH and treatment with prednisolone (PSL) 0.5 mg/kg per day, his urinary output improved, along with improvement of his renal function; therefore hemodialysis was finally discontinued. To our knowledge, this is the first case report of AIN induced by clomipramine.
我们描述了一名患有强迫性神经症的41岁男性,他在接受盐酸氯米帕明(CPH)治疗6周期间因急性间质性肾炎(AIN)而发生急性肾衰竭(ARF)。服用CPH后,他出现低热、轻度关节痛、食欲减退和腹泻。入院时,他的血清肌酐(sCr)为7.31mg/dl,肌酐清除率(Ccr)为2.5ml/min。随后他出现无尿,需要进行血液透析。肾活检显示AIN伴弥漫性单核细胞浸润。停用CPH并每天使用0.5mg/kg泼尼松龙(PSL)治疗后,他的尿量增加,肾功能也有所改善;因此最终停止了血液透析。据我们所知,这是首例由氯米帕明引起的AIN病例报告。